Equity strategies

Carmignac Emergents

Emerging marketsSRI Fund Article 9
Share Class

FR0010149302

Key documents
Asset Allocation
Equities95.8 %
Other4.2 %
Data as of:  Apr 11, 2025.
Risk Indicator

1

2

3

4

5

6

7

Lowest risk Highest risk
Recommended Minimum Investment Horizon
5 years
Cumulative Performance since launch
+ 628.6 %
+ 22.0 %
+ 25.3 %
+ 1.0 %
- 6.4 %
From 03/02/1997
To 17/04/2025
Calendar Year Performance 2024
+ 5.2 %
+ 1.4 %
+ 18.8 %
- 18.6 %
+ 24.7 %
+ 44.7 %
- 10.7 %
- 15.6 %
+ 9.5 %
+ 4.6 %
Net Asset Value
1110.72 €
Asset Under Management
777 M €
Net Equity Exposure31/03/2025
97.3 %
SFDR - Fund Classification

Article

9
Data as of:  Apr 17, 2025.
​Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged. The Sustainable Finance Disclosure Regulation (SFDR) 2019/2088 is a European regulation that requires asset managers to classify their funds as either 'Article 8' funds, which promote environmental and social characteristics, 'Article 9' funds, which make sustainable investments with measurable objectives, or 'Article 6' funds, which do not necessarily have a sustainability objective. For more information please refer to https://eur-lex.europa.eu/eli/reg/2019/2088/oj.

Carmignac Emergents fund performance

Take a look at the Fund's performance supported by our Fund managers’ market commentary and strategy insight.

Our monthly comments

Data as of:  Mar 31, 2025.
Fund management team
[Management Team] [Author] Hovasse Xavier

Xavier Hovasse

Head of Emerging Equities, Fund Manager

Market environment

  • The emerging equities markets fell back in March, but nevertheless outperformed the developed market indices. (Hang Seng -3.0%, KOSPI -6.3%, BSE SENSEX +4.2%, BOVESPA +4.6%).
  • On the geopolitical front, Donald Trump's administration continues to threaten its main trading partners by increasing tariffs in many sectors, including the automotive industry.
  • The National People's Congress met for the annual ‘Two Sessions’ to decide the country's policy direction and announce its growth target of +5% for the year 2025.
  • The government has stated its intention to support the consumer, marking a major shift in the country's growth model, which is now centred on domestic consumption.
  • In South Korea, the financial regulator has reinstated short selling. Measures had been put in place in November 2023 following illegal short selling offences. The lifting of restrictions is intended to encourage the comeback of institutional investors.
  • Finally, in India, after several months of underperformance, the markets have experienced a technical rebound.

Performance commentary

  • In this context, the fund posted a negative performance, as did its reference indicator.
  • Our main detractor was Taiwan's TSMC, following the downward trend of the American tech giants, penalised by global economic uncertainties. As a result, our positions in Elite Material and Lite-On also had a negative impact on our portfolio.
  • Our portfolio of Chinese stocks weighed on the fund's good performance. We can mention the decline in the stock of Beike, a provider of transactional services in the real estate sector, which saw its stock fall following the publication of its quarterly results, which were disappointing, particularly in terms of profitability.
  • In India, the price of Kotak Mahindra stock continued to rise in 2025, benefiting from the appointment of a new chief technology officer, a major turning point in the bank's technological leadership.
  • Finally, our Latin American portfolio was unable to support the portfolio over the period, as was the case with the MercadoLibre stock, which fell back in March after a strong start to the year.

Outlook strategy

  • Despite the uncertainties related to D. Trump's policies, we remain constructive on emerging equities, believing that current valuations reflect a pessimistic scenario. Moreover, emerging markets are benefiting from the uncertainty in the United States: Trump's policies seem to have the opposite effect, benefiting emerging markets.
  • We remain constructive on China, given the change in perception. The markets realise that geopolitical tensions are hurting China but are not destroying it. Moreover, technological progress, particularly in AI and productivity, should provide further stimulus to the economy. This is why we want to maintain a decent exposure to China, with a slight underweight. Our Chinese portfolio is mainly composed of technology/innovative companies. Conversely, we avoid the old economy and cyclical sectors.
  • We are maintaining a significant allocation to India, where the long-term outlook remains promising (strong growth, political stability, healthy current account) despite the recent weakness. Our trip to India confirmed the country's promising outlook and the recent correction offers us interesting entry points on stocks that we are following.
  • We took advantage of this correction to increase our exposure to India by strengthening our positions in the e-commerce, tech and insurance sectors, which have fallen sharply. We are increasing our stake in PB Fintech (Policybazaar), the leader in online insurance services, capturing 21% of all new insurance products sold in India thanks to its unique platform.
  • Finally, we remain constructive on our Latin American portfolio, where valuations remain attractive. Despite the tariff risks, we remain constructive on Mexico. President Sheinbaum has managed to maintain good relations with D. Trump. Meanwhile, in Brazil, despite the significant rebound since the beginning of the year, we are maintaining our Brazilian stocks (particularly in energy infrastructure companies) due to their attractive risk/return profile.

Performance Overview

Data as of:  Apr 17, 2025.
​Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). Morningstar Rating™ :  © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.​From 01/01/2013 the equity index reference indicators are calculated net dividends reinvested. The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Source: Carmignac at 22/04/2025

Carmignac Emergents Portfolio overview

Below is an overview of the composition of the portfolio.

Geographical Breakdown

Data as of:  Mar 31, 2025.
Asia77.5 %
Latin America21.5 %
Eastern Europe1.0 %
View details

Key figures

Below are the key figures for the Fund, which will give you a clearer idea of the Fund's management and equity positioning.

Exposure Data

Data as of:  Mar 31, 2025.
Equity Investment Weight97.3 %
Net Equity Exposure97.3 %
Number of Equity Issuers38
Active Share82.9 %

The strategy in a nutshell

Fund Management Team
[Management Team] [Author] Hovasse Xavier

Xavier Hovasse

Head of Emerging Equities, Fund Manager

Related articles

Emerging equitiesApril 17, 2025English

Carmignac Portfolio Emergents: Letter from the Fund Manager

4 minute(s) read
Find out more
Emerging equitiesMarch 25, 2025English

Southeast Asia: A powerhouse in the making

Find out more
Emerging equitiesFebruary 6, 2025English

Carmignac Portfolio Emergents: Letter from the fund manager

3 minute(s) read
Find out more
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
The Fund is a common fund in contractual form (FCP) conforming to the UCITS Directive under French law.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.